Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.01%-37.41K | 47.53%-158.71K | 111.92%12.92K | -5.47%-54.97K | 43.13%-44.7K | -13.56%-71.97K | 20.98%-302.49K | 35.76%-108.4K | 22.79%-52.11K | -3.89%-78.61K |
| Net income from continuing operations | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Operating gains losses | -91.88%2.21K | -96.60%7.82K | -102.85%-6.69K | -1,986.37%-16.34K | 189.32%3.68K | 1,708.47%27.17K | 79,989.20%229.86K | 10,676.49%234.8K | 165.36%866 | -50.38%-4.12K |
| Depreciation and amortization | -37.71%702 | -12.51%4.13K | -17.82%807 | -28.51%1.08K | -2.52%1.12K | 3.97%1.13K | -0.96%4.72K | -17.27%982 | 4.43%1.51K | 1.41%1.15K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --0 | 87.87%-24.46K | --0 | --0 | --0 | -367.75%-24.46K | -730.88%-201.75K | -142.95%-210.89K | -109.09%-9.14K | -88.24%9.14K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other non cashItems | ---- | --20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 165.77%9.36K | 140.87%98.93K | 310.14%63.81K | 29.82%30.28K | 2,474.36%19.08K | -1,081.59%-14.23K | 137.75%41.07K | 388.06%15.56K | 597.25%23.32K | -34.54%741 |
| -Change in receivables | -154.22%-4.57K | 451.98%7.19K | 257.71%11.19K | -141.97%-6.75K | 3.51%-5.68K | 264.16%8.43K | -204.82%-2.04K | -34.38%-7.1K | 1,573.15%16.08K | -149.24%-5.89K |
| -Change in prepaid assets | -7.52%1.66K | 175.63%2.18K | 61.25%-3.21K | 0.00%1.8K | 0.00%1.8K | 0.06%1.8K | -120.63%-2.89K | -53.56%-8.27K | -0.06%1.8K | 0.06%1.8K |
| -Change in payables and accrued expense | 150.17%12.27K | 94.69%89.56K | 80.49%55.82K | 546.56%35.23K | 374.93%22.96K | -610.69%-24.46K | 3,322.62%46K | 487.18%30.93K | 826.70%5.45K | 138.30%4.84K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.01%-37.41K | 47.53%-158.71K | 111.92%12.92K | -5.47%-54.97K | 43.13%-44.7K | -13.56%-71.97K | 20.98%-302.49K | 35.76%-108.4K | 22.79%-52.11K | -3.89%-78.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -85.52%19.32K | 0 | 6.38K | 0 | 12.94K | 133.38K | 133.38K | 0 | 0 |
| Net PPE purchase and sale | ---- | --6.38K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | --0 | -90.30%12.94K | --0 | --0 | --0 | --12.94K | --133.38K | --133.38K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -85.52%19.32K | --0 | --6.38K | --0 | --12.94K | --133.38K | --133.38K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 50.31K | 0 | ||||||||
| Net issuance payments of debt | --50.31K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --50.31K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -68.20%65K | -45.28%204.4K | -70.98%52.08K | -56.52%100.66K | -53.13%145.36K | -45.28%204.4K | -50.61%373.51K | -66.91%179.42K | -62.03%231.53K | -54.75%310.14K |
| Current changes in cash | 121.84%12.9K | 17.57%-139.4K | -48.27%12.92K | 6.77%-48.59K | 43.13%-44.7K | 6.85%-59.03K | 55.82%-169.12K | 114.80%24.98K | 22.79%-52.11K | -3.89%-78.61K |
| End cash Position | -46.42%77.89K | -68.20%65K | -68.20%65K | -70.98%52.08K | -56.52%100.66K | -53.13%145.36K | -45.28%204.4K | -45.28%204.4K | -66.91%179.42K | -62.03%231.53K |
| Free cash from | 48.01%-37.41K | 47.53%-158.71K | 111.92%12.92K | -5.47%-54.97K | 43.13%-44.7K | -13.56%-71.97K | 20.98%-302.49K | 35.76%-108.4K | 22.79%-52.11K | -3.89%-78.61K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.